Use case
See how brands and generics within a molecule or ATC group are performing over time.
4 min read
Comparing brands is one of the most common questions brand and market access teams ask.
Start with the molecule
Compare all rivaroxaban brands by package count and reimbursement for 2023 to 2025 and calculate their market shares.
Look at the whole group
Show the top 10 molecules in ATC group N05A by reimbursement in 2025.
See who leads
Which marketing-authorisation holders lead the denosumab market in 2025?
Keep in mind
Reimbursement is what public health insurance paid, not the manufacturer’s revenue.
The data covers reimbursed products only.
The most recent year is usually partial, so compare full years or equal periods.
